ABOUT AEGIRBIO

A JOINT VENTURE

Aegirbio is a joint venture combining core technologies from LifeAssays and Abreos Biosciences. LifeAssays is a diagnostics company based in Lund, Sweden, and owns the Magnia Point of Care and Point of Need reader technology. Abreos Biosciences is a San Diego, California, based biotech and has developed the Veritope chemistry platform for detecting levels of biologic drugs in patient samples. Following several years of successful collaboration, Lifeassays and Abreos Biosciences will combine their highly complementary technologies in Aegirbio to create a leader in therapeutic drug monitoring of biologic drugs.

MANAGEMENT TEAM

BOARD OF DIRECTORS